$HGBL
Heritage Global Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024123236 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $10.41M
YoY Change -33.06%
Cost Of Revenue $3.193M
YoY Change -45.33%
Gross Profit $7.217M
YoY Change -25.75%
Gross Profit Margin 69.33%
Selling, General & Admin $5.686M
YoY Change -16.46%
% of Gross Profit 78.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $152.0K
YoY Change 16.92%
% of Gross Profit 2.11%
Operating Expenses $5.686M
YoY Change -16.46%
Operating Profit $1.479M
YoY Change -46.59%
Interest Expense $117.0K
YoY Change -267.14%
% of Operating Profit 7.91%
Other Income/Expense, Net
YoY Change
Pretax Income $1.496M
YoY Change -44.86%
Income Tax $407.0K
% Of Pretax Income 27.21%
Net Earnings $1.089M
YoY Change -44.92%
Net Earnings / Revenue 10.46%
Basic Earnings Per Share $0.03
Diluted Earnings Per Share $0.03
COMMON SHARES
Basic Shares Outstanding 37.34M 37.34M
Diluted Shares Outstanding 37.19M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.57M
YoY Change 70.55%
Cash & Equivalents $26.57M
Short-Term Investments
Other Short-Term Assets $833.0K
YoY Change 22.5%
Inventory $4.721M
Prepaid Expenses
Receivables $877.0K
Other Receivables $3.959M
Total Short-Term Assets $36.96M
YoY Change 9.1%
LONG-TERM ASSETS
Property, Plant & Equipment $1.692M
YoY Change -2.08%
Goodwill $7.446M
YoY Change 0.0%
Intangibles $3.460M
YoY Change -10.15%
Long-Term Investments $21.45M
YoY Change 32.96%
Other Assets $64.00K
YoY Change -5.88%
Total Long-Term Assets $51.57M
YoY Change 1.99%
TOTAL ASSETS
Total Short-Term Assets $36.96M
Total Long-Term Assets $51.57M
Total Assets $88.53M
YoY Change 4.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.268M
YoY Change 7.88%
Accrued Expenses $802.0K
YoY Change 2.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $525.0K
YoY Change -84.09%
Total Short-Term Liabilities $20.72M
YoY Change 3.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.681M
YoY Change -16.78%
Total Long-Term Liabilities $1.681M
YoY Change -78.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.72M
Total Long-Term Liabilities $1.681M
Total Liabilities $22.40M
YoY Change -20.11%
SHAREHOLDERS EQUITY
Retained Earnings -$227.6M
YoY Change -4.32%
Common Stock $373.0K
YoY Change 0.27%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.852M
YoY Change 368.86%
Treasury Stock Shares
Shareholders Equity $66.13M
YoY Change
Total Liabilities & Shareholders Equity $88.53M
YoY Change 4.84%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $1.089M
YoY Change -44.92%
Depreciation, Depletion And Amortization $152.0K
YoY Change 16.92%
Cash From Operating Activities $5.524M
YoY Change -6.69%
INVESTING ACTIVITIES
Capital Expenditures $35.00K
YoY Change 75.0%
Acquisitions
YoY Change
Other Investing Activities $3.409M
YoY Change -152.21%
Cash From Investing Activities $3.374M
YoY Change -151.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.910M
YoY Change -685.59%
NET CHANGE
Cash From Operating Activities 5.524M
Cash From Investing Activities 3.374M
Cash From Financing Activities -6.910M
Net Change In Cash 1.988M
YoY Change 261.45%
FREE CASH FLOW
Cash From Operating Activities $5.524M
Capital Expenditures $35.00K
Free Cash Flow $5.489M
YoY Change -6.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000849145
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39471
dei Entity Registrant Name
EntityRegistrantName
HERITAGE GLOBAL INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-2291344
dei Entity Address Address Line1
EntityAddressAddressLine1
12625 High Bluff Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 305
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
847-0659
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
dei Trading Symbol
TradingSymbol
HGBL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37341185
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26571000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12279000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
130000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
132000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
877000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1910000
CY2024Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
422000
CY2023Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
650000
CY2024Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
3959000
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6581000
CY2024Q3 us-gaap Inventory Net
InventoryNet
4721000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5074000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
833000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
448000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
36961000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
26292000
CY2024Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
7337000
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
10890000
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
21447000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
21361000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2381000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2539000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1692000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1705000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3460000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3753000
CY2024Q3 us-gaap Goodwill
Goodwill
7446000
CY2023Q4 us-gaap Goodwill
Goodwill
7446000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7740000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9115000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67000
CY2024Q3 us-gaap Assets
Assets
88528000
CY2023Q4 us-gaap Assets
Assets
83168000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6268000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7237000
CY2024Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
13125000
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
4975000
CY2024Q3 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
525000
CY2023Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
1733000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
802000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
789000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
20720000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14734000
CY2024Q3 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
0
CY2023Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
5495000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1681000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1859000
CY2024Q3 us-gaap Liabilities
Liabilities
22401000
CY2023Q4 us-gaap Liabilities
Liabilities
22088000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
563
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
563
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
563
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
563
CY2024Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2023Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
6000
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
6000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37341185
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37157616
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36343561
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36761441
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
373000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
372000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
295241000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
294522000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-227641000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-233026000
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
997624
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
396175
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
1852000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
794000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
66127000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
61080000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
88528000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83168000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10410000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15551000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34594000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45261000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5686000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6806000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18390000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19546000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
152000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
132000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
440000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
373000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
9031000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
12774000
us-gaap Costs And Expenses
CostsAndExpenses
29635000
us-gaap Costs And Expenses
CostsAndExpenses
36172000
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
100000
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2622000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
675000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1479000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2769000
us-gaap Operating Income Loss
OperatingIncomeLoss
7581000
us-gaap Operating Income Loss
OperatingIncomeLoss
9764000
CY2024Q3 hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
-17000
CY2023Q3 hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
56000
hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
183000
hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
225000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1496000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2713000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7398000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9539000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
407000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
736000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2013000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1954000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1089000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1977000
us-gaap Net Income Loss
NetIncomeLoss
5385000
us-gaap Net Income Loss
NetIncomeLoss
7585000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36576931
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36742018
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36641820
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36675838
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37189029
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37647321
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37292200
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37605363
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.2
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
61080000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-75000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
228000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1799000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
63032000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-6000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
290000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
2497000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
65813000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
283000
CY2024Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1058000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1089000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
66127000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
48299000
CY2023Q1 hgbl Cumulative Change In Accounting Principle
CumulativeChangeInAccountingPrinciple
-231000
CY2023Q1 hgbl Balance As Of January12023 As Adjusted For Change In Accounting Principle
BalanceAsOfJanuary12023AsAdjustedForChangeInAccountingPrinciple
48068000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
152000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
179000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2829000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
51233000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
228000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2779000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
54245000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
175000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1977000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
56398000
us-gaap Profit Loss
ProfitLoss
5385000
us-gaap Profit Loss
ProfitLoss
7585000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-77000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
76000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2622000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
675000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
228000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-632000
hgbl Noncash Lease Expense
NoncashLeaseExpense
484000
hgbl Noncash Lease Expense
NoncashLeaseExpense
483000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
440000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
373000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1375000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1170000
us-gaap Share Based Compensation
ShareBasedCompensation
801000
us-gaap Share Based Compensation
ShareBasedCompensation
582000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1032000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1910000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-353000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-173000
hgbl Other Current Assets
OtherCurrentAssets
-382000
hgbl Other Current Assets
OtherCurrentAssets
428000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-965000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2869000
hgbl Increase Decrease Of Payables To Sellers
IncreaseDecreaseOfPayablesToSellers
8150000
hgbl Increase Decrease Of Payables To Sellers
IncreaseDecreaseOfPayablesToSellers
6996000
hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-492000
hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-469000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13254000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12575000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
5047000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
27636000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
9039000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
6147000
hgbl Cash Received On Transfer Of Notes Receivable To Partners
CashReceivedOnTransferOfNotesReceivableToPartners
0
hgbl Cash Received On Transfer Of Notes Receivable To Partners
CashReceivedOnTransferOfNotesReceivableToPartners
8851000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
343000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
6465000
hgbl Return Of Investment In Equity Method Investments
ReturnOfInvestmentInEquityMethodInvestments
2744000
hgbl Return Of Investment In Equity Method Investments
ReturnOfInvestmentInEquityMethodInvestments
4124000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2622000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
675000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
134000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
237000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8881000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14541000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
13000000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
6704000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
8039000
hgbl Proceeds From Issuance Of Notes Payable To Third Parties
ProceedsFromIssuanceOfNotesPayableToThirdParties
0
hgbl Proceeds From Issuance Of Notes Payable To Third Parties
ProceedsFromIssuanceOfNotesPayableToThirdParties
36000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
81000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
120000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1058000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7843000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4877000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
14292000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2911000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12279000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12667000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26571000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15578000
us-gaap Income Taxes Paid
IncomeTaxesPaid
682000
us-gaap Income Taxes Paid
IncomeTaxesPaid
547000
us-gaap Interest Paid Net
InterestPaidNet
326000
us-gaap Interest Paid Net
InterestPaidNet
323000
us-gaap Notes Reduction
NotesReduction
2487000
us-gaap Notes Reduction
NotesReduction
0
hgbl Non Cash Change In Lease Liabilities And Right Of Use Assets
NonCashChangeInLeaseLiabilitiesAndRightOfUseAssets
327000
hgbl Non Cash Change In Lease Liabilities And Right Of Use Assets
NonCashChangeInLeaseLiabilitiesAndRightOfUseAssets
405000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the Company’s unaudited condensed consolidated interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant estimates include the assessment of collectability of revenue recognized and the valuation of accounts receivable and notes receivable, inventory, investments, goodwill and intangible assets, liabilities, deferred income tax assets and liabilities, including projecting future years’ taxable income, and stock-based compensation. These estimates have the potential to significantly impact our condensed consolidated interim financial statements, either because of the significance of the financial statement item to which they relate, or because they require judgment and estimation due to the uncertainty involved in measuring, at a specific point in time, events that are continuous in nature.</span></p>
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
500000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
500000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
51600000
CY2023Q4 hgbl Percentage Of Amortization Cost
PercentageOfAmortizationCost
0.59
CY2023Q4 us-gaap Debt Securities Held To Maturity Maturity After One Through Five Years Weighted Average Yield
DebtSecuritiesHeldToMaturityMaturityAfterOneThroughFiveYearsWeightedAverageYield
0.015
us-gaap Financing Receivable Allowance For Credit Loss Loan Purchased
FinancingReceivableAllowanceForCreditLossLoanPurchased
1000000
us-gaap Financing Receivable Allowance For Credit Loss Loan Purchased
FinancingReceivableAllowanceForCreditLossLoanPurchased
1100000
us-gaap Loans And Leases Receivable Gain Loss On Sales Net
LoansAndLeasesReceivableGainLossOnSalesNet
300000
CY2024Q3 hgbl Loans And Leases Receivable Nonaccrual Of Interest
LoansAndLeasesReceivableNonaccrualOfInterest
1500000
CY2024Q3 us-gaap Net Investment In Lease Nonaccrual
NetInvestmentInLeaseNonaccrual
24000000
CY2023Q4 us-gaap Net Investment In Lease Nonaccrual
NetInvestmentInLeaseNonaccrual
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Specialty Lending - Concentration and credit risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2024, the Company held a gross balance of investments in notes receivable of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">32.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, recorded in both notes receivable and equity method investments, and consisting of one borrower’s note balance of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">22.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">70</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% as of September 30, 2024, as compared to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">62</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% as of December 31, 2023. The Company does not intend to hold highly concentrated balances due from one borrower as part of its long-term strategy but may, in the short term, have concentration risk on its path to an established and diversified portfolio.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company does not evaluate concentration risk solely based on balance due from specific borrowers, but also considers the number of portfolio purchases, type of charged off accounts within the portfolio, and the seller of the portfolio when determining the overall risk. Of the balance due from one borrower of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">22.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, there are </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> distinct loan agreements. The underlying portfolio of accounts are diversified throughout FinTech loans, installment loans and credit card accounts, and further diversified amongst six separate sellers of these charged off portfolios.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company mitigates this concentration risk by requiring, and monitoring, security from each borrower consisting of their charged off and nonperforming receivable portfolios. The Company engages in a due diligence process that leverages its valuation expertise and knowledge in the underlying nonperforming receivable portfolios marketplace. In the event of default, the Company is entitled to call the unpaid interest and principal balances and receive all net collections directly. The Company may also recover its investment by engaging a third party to collect on the underlying charged off or nonperforming receivable portfolio or the underlying portfolio can be sold through the Company's Brokerage segment. In certain cases, the Company’s recovery options may be subject to concurrence of the originator or other prior holder of the assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q3 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
32000000
CY2024Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
22500000
hgbl Borrowers Note Balance Percentage
BorrowersNoteBalancePercentage
0.70
CY2023 hgbl Borrowers Note Balance Percentage
BorrowersNoteBalancePercentage
0.62
CY2024Q3 hgbl Due From Borrower
DueFromBorrower
22500000
hgbl Number Of Distinct Portfolio Purchases And Loan Agreements
NumberOfDistinctPortfolioPurchasesAndLoanAgreements
11
CY2024Q3 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
100000
CY2023Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
100000
CY2024Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
100000
CY2023Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
100000
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
10900000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
17500000
us-gaap Notes Issued1
NotesIssued1
4500000
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
8800000
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
2500000
CY2023Q4 hgbl Impaired Financing Receivables Unpaid Principal Balance
ImpairedFinancingReceivablesUnpaidPrincipalBalance
18262000
hgbl Origination Of Notes Receivable
OriginationOfNotesReceivable
5047000
hgbl Transfer Of Notes To And From Senior Lender
TransferOfNotesToAndFromSeniorLender
2487000
hgbl Principal Payment Of Note Receivable
PrincipalPaymentOfNoteReceivable
9039000
CY2024Q3 hgbl Impaired Financing Receivables Unpaid Principal Balance
ImpairedFinancingReceivablesUnpaidPrincipalBalance
11783000
hgbl Deferred Finance Fees And Costs Net
DeferredFinanceFeesAndCostsNet
-65000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
-422000
CY2024Q3 us-gaap Notes Receivable Net
NotesReceivableNet
11296000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
300000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
400000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
12750
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2265350
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.71
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
907000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
35000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.7
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
13750
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
12750
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.87
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2273850
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.73
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
897000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1626600
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.42
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M18D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
879000
us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
the Company’s shares of Series N preferred stock, each of which is convertible to 40 common shares, have the right to receive dividends or dividend equivalents should the Company declare dividends on its common stock.
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36576931
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36742018
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36641820
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36675838
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
612098
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
905303
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
650380
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
929525
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37189029
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37647321
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37292200
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37605363
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
900000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
900000
hgbl Number Of Locations
NumberOfLocations
4
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2381000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2539000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2483000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2648000
CY2019Q1 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0525
CY2022Q3 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.055
CY2023Q2 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0725
CY2024Q3 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0625
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0551
us-gaap Operating Lease Expense
OperatingLeaseExpense
600000
us-gaap Operating Lease Expense
OperatingLeaseExpense
600000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
199000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
807000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
829000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
573000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
299000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2707000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
224000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2483000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1316000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
293000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1023000
CY2023Q4 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
3753000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
293000
CY2024Q3 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
3460000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2024Q3 us-gaap Acquired Finite Lived Intangible Asset Residual Value
AcquiredFiniteLivedIntangibleAssetResidualValue
0
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
98000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
263000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
186000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
32000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
32000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
412000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1023000
CY2024Q3 us-gaap Goodwill
Goodwill
7446000
CY2023Q4 us-gaap Goodwill
Goodwill
7446000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q3 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
525000
CY2023Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
1733000
CY2024Q3 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
0
CY2023Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
5495000
CY2024Q3 us-gaap Loans Payable
LoansPayable
525000
CY2023Q4 us-gaap Loans Payable
LoansPayable
7228000
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
50300000
hgbl Operating Loss Carryforwards Expiring Year
OperatingLossCarryforwardsExpiringYear
2024
us-gaap Tax Credit Carryforward Description
TaxCreditCarryforwardDescription
These rules, in general, provide that an ownership change occurs when the percentage shareholdings of 5% direct or indirect stockholders of a loss corporation have, in aggregate, increased by more than 50 percentage points during the immediately preceding three years.
hgbl Operating Loss Carryforward Limitations On Use
OperatingLossCarryforwardLimitationsOnUse
2500000
hgbl Operating Loss Carryforward Limitations On Use
OperatingLossCarryforwardLimitationsOnUse
1700000
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2200000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2200000

Files In Submission

Name View Source Status
0000950170-24-123236-index-headers.html Edgar Link pending
0000950170-24-123236-index.html Edgar Link pending
0000950170-24-123236.txt Edgar Link pending
0000950170-24-123236-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hgbl-20240930.htm Edgar Link pending
hgbl-20240930.xsd Edgar Link pending
hgbl-ex10_2.htm Edgar Link pending
hgbl-ex31_1.htm Edgar Link pending
hgbl-ex31_2.htm Edgar Link pending
hgbl-ex32_1.htm Edgar Link pending
hgbl-ex32_2.htm Edgar Link pending
img162495210_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hgbl-20240930_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending